AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $699,000 | -43.5% | 345,850 | 0.0% | 0.07% | -46.3% |
| Q1 2019 | $1,238,000 | +128.0% | 345,850 | 0.0% | 0.12% | +78.3% |
| Q4 2018 | $543,000 | -38.6% | 345,850 | 0.0% | 0.07% | -22.5% |
| Q3 2018 | $885,000 | +31.3% | 345,850 | 0.0% | 0.09% | +2.3% |
| Q2 2018 | $674,000 | +7.2% | 345,850 | 0.0% | 0.09% | -2.2% |
| Q1 2018 | $629,000 | -58.0% | 345,850 | 0.0% | 0.09% | -72.3% |
| Q4 2017 | $1,498,000 | -29.5% | 345,850 | 0.0% | 0.32% | -25.2% |
| Q3 2017 | $2,124,000 | -12.7% | 345,850 | -34.5% | 0.43% | -30.0% |
| Q2 2017 | $2,433,000 | -58.4% | 527,842 | 0.0% | 0.61% | -64.3% |
| Q1 2017 | $5,843,000 | +57.2% | 527,842 | 0.0% | 1.72% | +40.3% |
| Q4 2016 | $3,716,000 | -17.3% | 527,842 | 0.0% | 1.22% | -12.5% |
| Q3 2016 | $4,492,000 | -36.9% | 527,842 | 0.0% | 1.40% | -28.0% |
| Q2 2016 | $7,121,000 | -3.6% | 527,842 | 0.0% | 1.94% | +4.9% |
| Q1 2016 | $7,390,000 | – | 527,842 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 178,091 | $703,459 | 0.52% |